tocophersolan has been researched along with Malabsorption Syndromes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blond, E; Caussy, C; Charriere, S; Cuerq, C; Di Filippo, M; Drai, J; Henin, E; Lachaux, A; Laveille, C; Levy, E; Marçais, C; Michalski, MC; Moulin, P; Peretti, N; Poinsot, P; Reboul, E; Restier, L; Sassolas, A | 1 |
Kalbfleisch, J; Mohon, R; Papas, K | 1 |
Accurso, F; Butler-Simon, N; Hammond, K; Heubi, JE; Heyman, M; Iannaccone, ST; McClung, HJ; Riely, C; Sinatra, F; Sokol, RJ | 1 |
1 trial(s) available for tocophersolan and Malabsorption Syndromes
Article | Year |
---|---|
Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients.
Topics: Adolescent; Adult; alpha-Tocopherol; Antioxidants; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Child; Cystic Fibrosis; Dosage Forms; gamma-Tocopherol; Humans; Intestinal Absorption; Lipids; Malabsorption Syndromes; Polyethylene Glycols; Solubility; Solvents; Tocopherols; Vitamin E; Water | 2007 |
2 other study(ies) available for tocophersolan and Malabsorption Syndromes
Article | Year |
---|---|
Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.
Topics: Abetalipoproteinemia; Adult; alpha-Tocopherol; Biological Availability; Case-Control Studies; Drug Compounding; Drug Storage; Female; Humans; Hypobetalipoproteinemias; Intestinal Absorption; Malabsorption Syndromes; Male; Middle Aged; Safety; Vitamin E | 2018 |
Vitamin E deficiency neuropathy in children with fat malabsorption. Studies in cystic fibrosis and chronic cholestasis.
Topics: Cholestasis; Cystic Fibrosis; Humans; Infant; Malabsorption Syndromes; Neuromuscular Diseases; Polyethylene Glycols; Prospective Studies; Vitamin E; Vitamin E Deficiency | 1989 |